Patents by Inventor Stephane David Levy

Stephane David Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Organic Compounds
    Publication number: 20090176857
    Abstract: The invention relates to a pharmaceutical composition, use, or method in the treatment of Irritable Bowel Syndrome (IBS) characterized by mixed or alternating bowel habits based on a modification of the Rome II criteria (IBS-M), with 5-hydroxytryptamine type-4 receptor agonists (5-HT4 agonists), in particular tegaserod.
    Type: Application
    Filed: November 30, 2006
    Publication date: July 9, 2009
    Inventor: Stephane David Levy